Related Funds
Fund Name | Location |
Blue Angels Investment Group | Boston, Massachusetts, United States |
Cambia Health Solutions | Oregon, Portland, United States |
Crossroads Capital | Colorado, Greenwood Village, United States |
DJI | China, Guangdong, Shenzhen |
JHC Ventures | - |
Kashen Jinsheng Tianhua | - |
KLEOSS Capital | Gauteng, Johannesburg, South Africa |
Northwater Capital | Canada, Ontario, Toronto |
octopus | Arizona, Scottsdale, United States |
Satya Capital | England, London, United Kingdom |
SEGNEL Ventures | Central, Central Region, Singapore |
Seibu Shinkin Capital | Japan, Kumamoto, Kumamoto Prefecture |
Shengjing Technology | - |
Shinhan Capital | Seoul, Seoul-t'ukpyolsi, South Korea |
Sino Pacific Capital | China, Guangdong, Shenzhen |
Timken Foundation of Canton | - |
University of Toronto Asset Management Corporation | Canada, Ontario, Toronto |
WP Global Partners | Chicago, Illinois, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
NextPoint Therapeutics | $42M | 14 Feb 2024 | Cambridge, Massachusetts, United States | ||
SK biopharmaceuticals | $180M | 26 Nov 2021 | Seongnam, Kyonggi-do, South Korea | ||
Ignis Therapeutics | $180M | 11 Nov 2021 | Shanghai, Shanghai, China | ||
Allay Therapeutics | $60M | 15 Sep 2021 | Menlo Park, California, United States | ||
MycoWorks | $45M | 13 Oct 2020 | California, United States | ||
Geltor | $91M | 27 Jul 2020 | California, United States | ||
Ascletis | $100M | 03 Jan 2017 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
NextPoint Therapeutics | $42M | 14 Feb 2024 | Cambridge, Massachusetts, United States | ||
SK biopharmaceuticals | $180M | 26 Nov 2021 | Seongnam, Kyonggi-do, South Korea | ||
Ignis Therapeutics | $180M | 11 Nov 2021 | Shanghai, Shanghai, China | ||
Allay Therapeutics | $60M | 15 Sep 2021 | Menlo Park, California, United States | ||
MycoWorks | $45M | 13 Oct 2020 | California, United States | ||
Geltor | $91M | 27 Jul 2020 | California, United States | ||
Ascletis | $100M | 03 Jan 2017 | North Carolina, United States |